Pharma firm’s facility to treat rare disorders will create 50 jobs

A niche pharmaceutical company, Alexion Pharmaceuticals, has announced that it will be creating 50 jobs in Ireland with the establishment of a new facility to treat ultra-rare disorders.

The company is expanding its global presence with the opening of a new office and laboratory facility in Dublin in conjunction with the company’s decision to establish a global supply chain facility in Ireland.

The Irish facility will supply soliris (eculizumab) to patients suffering with two severe and life-threatening ultra-rare disorders PNH and aHUS.